NewsBenzingaBTIG、Bicara Therapeuticsの「買い」を再確認、目標株価39ドルを維持 BTIG、Bicara Therapeuticsの「買い」を再確認、目標株価39ドルを維持 Benzinga 2026.10.19 09:56 (GMT+0) Open on Benzinga Other news Homebuilder Sentiment Hits 2012 Lows As Stocks Trade Like They Did During COVID-19 Pandemic FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated Nvidia Researchers Using Supercomputer Jupiter For Fault-Tolerant Computing Simulation Gilead Bolsters Inflammatory Bowel Disease Pipeline With Promising Mid-Stage Trial Success SpaceX Stock Shakeup: Elon Musk’s Stock Giveaway Meets Insider Sales Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4
